Sort by: Helpfulness | Most Recent
1 patient evaluation for raltegravir taken for the purpose of 'HIV (Human Immunodeficiency Virus)' with a perceived effectiveness rating of Moderate
|Date||Dosage||Perceived effectiveness||Side Effects||Adherence||Burden|
|Aug 08, 2012||800 mg Daily||Moderate||Mild||Usually||Not at all|
|Jun 28, 2010||800 mg Daily||?Can't tell||Moderate||Always||Not at all|
2 additional evaluations for raltegravir are not currently shared publicly.